- Home
- VCEL vs SRPT Comparison
VCEL vs SRPT Comparison
Compare VCEL & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCEL | SRPT |
|---|---|---|
| Founded | 1989 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.4B |
| IPO Year | 1996 | 2000 |
Fundamental Metrics
Financial Performance| Metric | VCEL | SRPT |
|---|---|---|
| Price | $32.48 | $17.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 28 |
| Target Price | ★ $58.50 | $25.24 |
| AVG Volume (30 Days) | 527.5K | ★ 2.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | $276,259,000.00 | ★ $2,198,237,000.00 |
| Revenue This Year | $19.10 | N/A |
| Revenue Next Year | $17.95 | N/A |
| P/E Ratio | $98.34 | ★ N/A |
| Revenue Growth | ★ 16.45 | 15.58 |
| 52 Week Low | $29.24 | $10.42 |
| 52 Week High | $48.75 | $76.33 |
Technical Indicators
Market Signals| Indicator | VCEL | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 49.32 |
| Support Level | $31.24 | $17.05 |
| Resistance Level | $38.48 | $19.55 |
| Average True Range (ATR) | 1.34 | 0.86 |
| MACD | -0.09 | 0.15 |
| Stochastic Oscillator | 31.94 | 75.15 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.